No Data
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin
Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin
Express News | Lobe Sciences Ltd: Expected That Company's Australian Subsidiary, Lobe Sciences Australia Pty Ltd., Will Become a Subsidiary of Alera
Express News | Lobe Sciences Ltd - Rick Goulburn Is Appointed as Chief Executive Officer of Alera Pharma, Inc
Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team
No Data